19th Vaccine Congress About

19th Vaccine Congress

7-10 September 2025 | Kyoto, Japan

Submit your abstracts by 2 May 2025!

Join us for the 19th Vaccine Congress

Join leading experts at the 19^th Vaccine Congress who will share their knowledge on the current developments and discoveries in the field.

#19vaccinecongress 新しいタブ／ウィンドウで開く

Organized by Vaccine 新しいタブ／ウィンドウで開く, the premier journal for those interested in vaccine science, the congress will bring together leading experts from all over the world to share the latest cutting-edge discoveries in the field. Join us to present your own research, as well as form new relationships with potential collaborators!

The following quotes are from attendees that have visited previous Vaccine Congresses.

“A climate of collegiality and constructive feedback.”

“A good platform to meet the community, talk, discuss and share.”

“Really nice mix across spectrum of vaccine research from hesitancy and uptake to developing new vaccines - haven't come across that mix at other conferences.”

“This meeting was very well organized, professional, and timely. Relevant topics and state-of-the-art methods were presented by high caliber speakers. Multicultural attendance, panel and round table discussions, frequent breaks, provision of meals, and poster sessions allowed for considerable opportunity to network, deliberate, and make plans for moving science forward.”

“Great scientific content, easy to talk to people active in this field.”

“The Vaccine Congress brings together a wealth of global expertise, from basic science to service delivery, in one of the most important and powerful areas of contemporary international public health. It is instructive and inspirational in equal measure.”

Sebastian Taylor, Head of Global Operations, Royal College of Paediatrics and Child Health, London, UK

“The Vaccine Congress has an exciting agenda that will be of interest to all vaccinologists.”

Daniel Salmon, John Hopkins University, USA

Abstracts are now invited on the following topics. They should be submitted using the online abstract submission system 新しいタブ／ウィンドウで開く.

Abstract Submission Deadline: 2 May 2025

Conference topics

Systems Vaccinology
Vaccines against STIs
Models for Vaccine Development and Evaluation
Immunization of Special Risk Groups and/or Maternal Immunization
Veterinary Vaccines
Vaccines against Respiratory Diseases (Influenza/Covid/RSV): Focus on Mucosal Vaccines
Social and Political Impacts of Vaccination and Vaccine Policy
Vaccines for Emerging Pathogens and One Health
Vaccines for Neglected Diseases
Vaccine Durability, Formulation and Administration
Vaccine Production and Process Technology
Hot Topics: SFTSV, Marburg, mpox, etc.

Keynote and plenary talks from renowned speakers

The program will include invited plenary lectures, contributed talks and poster sessions highlighting the latest research in vaccine science. The program will be curated by a committee of world class academic leaders in their respective fields.

View all Committee & Speakers

Microphone in front of business people at conference

Discover and participate

Discover conference topics and learn about related events and how you can participate.

More information on how to participate

Side view of person typing on laptop keyboard

Sponsors & Exhibitors

Choose from a variety of sponsorship and commercial options to raise your profile and position your company as a thought leader in the community.

View all Sponsors & Exhibitors

Conference deadlines

Abstract submission deadline for oral presentations – 2 May 2025

Submission for late posters and hot topics - 11 July 2024

Author notification deadline – 18 June 2025

Author registration deadline – 11 July 2025

Early bird deadline – 11 July 2025

Supporting publications

Vaccine

The official journal of The Japanese Society for Vaccinology 新しいタブ／ウィンドウで開く.

Editor-in-Chief: Gregory A. Poland, MD

Vaccine 新しいタブ／ウィンドウで開く is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories 新しいタブ／ウィンドウで開く as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions. We also invite authors to submit relevant basic science and clinical reviews, methodological articles, opinion and commentary pieces, visual pieces, and letters. Authors are required to consult the Guide for Authors 新しいタブ／ウィンドウで開く as the submission guidelines are dynamic and therefore subject to change.

Would you like to be a reviewer for Vaccine? If you think you would be a good referee for the Vaccine journal you can volunteer to review by visiting the Elsevier Reviewer Hub 新しいタブ／ウィンドウで開く, where you can register your interest in volunteering for Vaccine. Further information can be found on our Reviewer page.

Vaccine 新しいタブ／ウィンドウで開く Special Issue

Special Issue to summarize the latest developments presented at the 19^th Vaccine Conference held in Kyoto, Japan, 2025.

We are pleased to announce that selected papers presented at the 19^th Vaccine conference will be published in a Special Issue of Vaccine 新しいタブ／ウィンドウで開く to summarize the latest progress in the field of Vaccinology. The special issue will be open for submissions from October 2025 onwards.

To discuss potential ideas, the suitability of your manuscript, or for further information please contact Dior Beerens: [email protected] 新しいタブ／ウィンドウで開く(please do not email credit card information under any circumstances).

We look forward to receiving your contribution to the conference issue.

Vaccine: X

Vaccine: X 新しいタブ／ウィンドウで開く is the open access companion journal of Vaccine and has the same aims and scope. The journal offers authors who want to publish in a gold open access journal the opportunity to make their work immediately and permanently accessible.